ArticleFuture oncology (London, England)2025

METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.

Jialing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.